• SENSEX 78,553.20
    1,508.91 (+1.96%)
  • BANKNIFTY 54,290.20
    1,172.45 (+2.21%)
  • Avenue Super.
    4,395.00 5,484.00(%)
  • Infosys
    1,429.40 2,006.80(%)
  • Waaree Renewab.
    1,170.00 3,037.75(%)
  • Mazagon Dock
    2,695.15 1,046.00(%)
  • ICICI Bank
    1,408.60 1,408.60(%)
  • HDFC Bank
    1,919.35 1,919.35(%)
  • Nip. India Nifty
    266.74 292.58(%)
  • Tata Motors
    626.90 1,179.05(%)
  • KFin Technolog.
    1,145.00 1,640.00(%)
  • Coforge
    6,668.00 10,017.95(%)
  • Angel One
    2,385.85 3,502.60(%)
  • Wipro
    232.20 208.40(%)
  • Glenmark Pharma.
    1,336.95 985.60(%)
  • St Bk of India
    801.00 912.10(%)
  • IndusInd Bank
    800.85 1,550.00(%)
  • SpiceJet
    51.29 79.90(%)
  • Bharti Airtel
    1,897.95 1,897.95(%)
  • Suzlon Energy
    55.71 86.04(%)
  • Reliance Industr
    1,279.45 1,608.95(%)
  • NBCC
    100.00 139.83(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shree Ganesh Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71615.0
  • ISIN : INE414Y01015
726.50 18 (2.58%)
  • As on 17 Apr 2025 (EOD)

  • Today’s Low

    695.10

  • Today’s High

    730.00

  • Open

    696.00

  • Perv Close

    708.20

  • 52W Low

    557.95

  • 52W High

    950.05

Key Indicators

  • P/E(TTM)

    32.06

  • Mar.Cap (₹Cr.)

    932.58

  • Div & Yield %

    0.07

  • Book Value(₹)

    103.73

  • Debt-Equity Ratio

    2.58

  • AGM Date

    17-Apr-2025

  • EPS

    22.66

  • P/E Ratio

    32.06

Financials Ratios

  • Debt-Equity Ratio

    0.30

  • Mar.Cap (₹Cr.)

    932.58

  • RONW (%)

    23.02

  • ROCE (%)

    24.40

Score Board

  • Equity (₹ in Cr.)

    12.84

  • BV (₹)

    103.70

  • Sales( ₹ in Cr.)

    125.90

  • NP (in Cr.)

    28.12

  • NP Var(%)

    85.0

  • Div%

    5.0

  • CPS (₹)

    26.70

  • EPS (₹)

    21.90

  • Traded Value (₹ in Lakhs)

    909.09

  • 52 Week High

    950.05

  • 52 Week Low

    557.95

  • Price BSE

    708.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    909.09

  • P/C Ratio

    26.60

  • P/E Ratio

    32.30

  • Price Vs.BV

    21.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 125.90 91.36 71.29 49.08 58.43 35.31
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 125.90 91.36 71.29 49.08 58.43 35.31
Other Income 3.07 0.72 3.57 2.09 4.18 1.17
Stock Adjustments 4.88 0.69 0.40 3.97 -0.08 1.98
Total Income 133.85 92.77 75.26 55.14 62.53 38.46
EXPENDITURE :            
Raw Materials 63.36 48.61 38.11 26.47 35.97 20.92
Power and Fuel Cost 6.39 4.91 4.25 1.34 1.35 0.83
Employee Cost 8.41 5.97 2.95 2.43 2.17 1.63
Other Manufacturing Expenses 0.80 0.51 0.44 1.30 1.32 1.06
Selling and Administration Expenses 9.42 7.02 7.62 7.56 6.30 3.94
Miscellaneous Expenses 0.59 1.60 0.39 0.31 0.28 0.18
Employee Benefit Expenses 8.41 5.97 2.95 2.43 2.17 1.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 88.97 68.61 53.77 39.41 47.40 28.56
Operating Profit 44.88 24.16 21.49 15.74 15.12 9.90
Interest 0.60 0.18 0.15 0.07 0.14 0.20
Gross Profit 44.28 23.98 21.34 15.67 14.98 9.70
Depreciation 6.11 3.74 3.34 2.73 2.24 1.04
Profit Before Tax 38.17 20.24 18.00 12.94 12.74 8.66
Current Tax 9.38 5.34 4.65 3.23 3.18 2.19
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.67 -0.28 -0.04 -0.04 -0.06 0.24
Reported Net Profit 28.12 15.18 13.40 9.75 9.62 6.24
Extraordinary Items 0.00 0.01 -0.03 0.00 0.00 0.00
Adjusted Net Profit 28.12 15.17 13.43 9.75 9.62 6.24
Adjustment below Net Profit 0.00 0.00 -0.08 -1.54 0.00 0.00
P & L Balance brought forward 59.28 44.70 33.15 26.28 18.00 12.85
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.63 0.60 1.75 1.35 1.35 1.08
P & L Balance carried down 86.78 59.28 44.72 33.15 26.28 18.00
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 5.00 3.00 5.00 17.50 15.00 12.50
Dividend Per Share(Rs) 0.50 0.30 0.50 1.75 1.50 1.25
Earnings Per Share-Unit Curr 21.89 12.14 11.16 9.75 10.73 6.95
Earnings Per Share(Adj)-Unit Curr 21.89 12.14 11.08 8.07 7.96 5.16
Book Value 95.07 69.70 51.28 49.97 46.92 37.70
Book Value(Adj)-Unit Curr 95.07 69.70 50.92 41.35 34.81 27.97

Shareholding Pattern

  • Promoter Group

    72.80%

  • Public Share Holding

    27.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 10,568 0.08 10,568 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,334,976 72.72 9,334,976 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,345,544 72.80 9,345,544 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,000 0.01 1,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,000 0.01 1,000 1
2] Non Institution
Bodies Corporate 155,247 1.21 155,247 25
Clearing Members 6,128 0.05 6,128 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 89,663 0.70 89,663 247
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 43,542 0.34 43,542 90
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,464,909 11.41 1,464,909 25
Individuals holding nominal share capital up to Rs. 1 lakh 1,729,903 13.48 1,729,903 8,575
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 36 0.00 36 1
Others 1,648 0.01 1,648 2
Sub Total 3,491,076 27.19 3,491,076 8,969
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,837,620 100.00 12,837,620 8,978

Company Background

Shree Ganesh Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Shree Ganesh Remedies Ltd
  • BSE Code : 71615.0
  • ISIN : INE414Y01015

  • Incorporation Year

    1995

  • Registered Office

    Plot No 6011
    GIDC, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-227777

  • FAX

    91-2646-226422

  • Chairman

    Chandubhai Kothia

  • Managing Director

    Chandubhai Kothia

  • Company Secretary

    Aditya Vikrambhai Patel

  • Auditor

    Bansi S Mehta & Co/Chaudhary Shah & Associates LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Shree Ganesh Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shree Ganesh Rem 726.50 128.96 125.90 32.06 27.76
Abbott India 30,681.95 6,097.18 5,848.91 48.86 44.71
Astrazeneca Phar 8,749.25 1,330.33 1,295.53 225.55 33.26
P & G Health Ltd 5,229.25 1,166.89 1,151.26 36.69 39.76
Glaxosmi. Pharma 2,909.25 3,530.73 3,407.25 57.85 44.44
Cipla 1,515.45 17,645.00 16,574.34 25.98 20.10
Amrutanjan Healt 674.85 437.58 421.23 39.56 20.84
Guj. Themis Bio. 316.15 174.19 169.82 65.46 44.82
Fermenta Biotec. 274.60 315.24 307.09 26.03 4.10
Bliss GVS Pharma 124.90 638.96 605.46 28.58 11.19
Ambalal Sarabhai 39.16 11.70 3.81 16.74 1.92